Gimme Care review

One of the cheaper genuine month-to-month semaglutide rates here, with the standing figure confirmed in two places rather than one, a named legal entity, a displayed certification and an all-inclusive price. For most weight-loss shoppers that is a good offer. For this site's reader it is the wrong shape: there is no microdose product to step down to, and the flat-price sentence printed under the figure guarantees that taking a quarter of the dose costs what taking all of it costs. No dose range is published for that sentence to cover, and the refill cadence may not match the billing cadence.

Vs median

$15/mo below the $175 median across the 299 of 548 programs here that publish a plain monthly rate

Market

$59–$1,300/mo is the full published spread on this site

Structure

Same price at every dose

Consult

Included in the price

Dietitian

Not confirmed

Labs

Not required

Pricing

Flat at every dose

Gimme Care does not publicly identify the pharmacy that fills its prescriptions. No bloodwork is required before you start. A clinician review is included in the price.

Gimme Care, operated by Start Gimme LLC, is a direct-to-consumer telehealth brand selling compounded semaglutide and tirzepatide plus a range of injectables including sermorelin, NAD+, glutathione and B12 combinations. It competes explicitly on price, headlining industry-leading pricing with a footnoted comparison against other providers. Patients complete an online medical questionnaire, a licensed provider reviews it, and medication ships free from what the site calls U.S. FDA-regulated licensed compounding pharmacies, none named. It serves all 50 states plus the District of Columbia, takes no insurance and charges no membership fee, and states that the quoted price covers consultation, care, medication, supplies, shipping and support.

Sells no microdose product at all. A microdoser pays the full $160 or $199 for whatever fraction of the drug is prescribed, with no lower tier to step down to — and "same price at every dose" is precisely the sentence that guarantees it

• Publishes no milligram range anywhere, so the flat-price claim asserts flatness without ever naming the doses it covers
• Refills are described as shipping every 28 days while billing is described as monthly. If the charge follows the shipment cycle rather than the calendar, the real annual cost runs about 8.6% above the advertised figure times twelve
• No pharmacy is named — only "U.S. FDA-regulated" licensed compounding pharmacies
• The industry-leading-pricing comparison is footnoted as based on publicly available information with no date, no named competitors and no methodology
• No compounding facility designation is given anywhere on the site
• Compounded GLP-1s are not FDA-approved, and intentional microdosing is off-label and unproven

Gimme Care is one of 548 low-dose GLP-1 programs compared on this site, and 299 of them publish a monthly rate you can read before signing up. The full list puts every published price in one place, with the companies that pay us listed first — something we state there, on the page it applies to.

Intentional GLP-1 microdosing is off-label and unproven — no randomized trial has established that a sub-label dose does anything, and any dose belongs with a clinician who knows your history. If you are going to have that conversation, have it with real numbers.

• What the evidence actually shows
• What microdosing GLP-1 costs
• Low dose vs full dose
• What a flat price costs at a low dose
• The true annual cost of a plan